202 related articles for article (PubMed ID: 25986910)
21. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
Ha FJ; Nogic J; Montone RA; Cameron JD; Nerlekar N; Brown AJ
Cardiovasc Revasc Med; 2018; 19(7 Pt B):837-844. PubMed ID: 29685385
[TBL] [Abstract][Full Text] [Related]
22. Left Main Stenting in Comparison With Surgical Revascularization: 10-Year Outcomes of the (Left Main Coronary Artery Stenting) LE MANS Trial.
Buszman PE; Buszman PP; Banasiewicz-Szkróbka I; Milewski KP; Żurakowski A; Orlik B; Konkolewska M; Trela B; Janas A; Martin JL; Kiesz RS; Bochenek A
JACC Cardiovasc Interv; 2016 Feb; 9(4):318-327. PubMed ID: 26892080
[TBL] [Abstract][Full Text] [Related]
23. Drug-Eluting Versus Bare Metal Stents in Saphenous Vein Graft Intervention: An Updated Comprehensive Meta-Analysis of Randomized Trials.
Bhogal S; Panchal HB; Bagai J; Banerjee S; Brilakis ES; Mukherjee D; Kumar G; Shanmugasundaram M; Paul TK
Cardiovasc Revasc Med; 2019 Sep; 20(9):758-767. PubMed ID: 30503811
[TBL] [Abstract][Full Text] [Related]
24. Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?
Kansara P; Weiss S; Weintraub WS; Hann MC; Tcheng J; Rab ST; Klein LW;
JACC Cardiovasc Interv; 2015 Nov; 8(13):1647-56. PubMed ID: 26585614
[No Abstract] [Full Text] [Related]
25. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
[TBL] [Abstract][Full Text] [Related]
26. Are drug-eluting stents superior to bare metal stents when compared to coronary artery bypass surgery? Show me the data.
Rodriguez AE
Cardiovasc Revasc Med; 2013; 14(2):90-2. PubMed ID: 23290662
[TBL] [Abstract][Full Text] [Related]
27. [ESC/EACTS guidelines on myocardial revascularization 2018 : The most important innovations].
Neumann FJ; Hochholzer W; Siepe M
Herz; 2018 Dec; 43(8):689-694. PubMed ID: 30456630
[TBL] [Abstract][Full Text] [Related]
28. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
[TBL] [Abstract][Full Text] [Related]
29. The Bypass Angioplasty Revascularization in Type 1 and Type 2 Diabetes Study: 5-year follow-up of revascularization with percutaneous coronary intervention versus coronary artery bypass grafting in diabetic patients with multivessel disease.
Kapur A; Bartolini D; Finlay MC; Qureshi AC; Flather M; Strange JW; Hall RJ
J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):26-33. PubMed ID: 19797974
[TBL] [Abstract][Full Text] [Related]
30. Comparative Effectiveness and Safety of New-Generation Versus Early-Generation Drug-Eluting Stents According to Complexity of Coronary Artery Disease: A Patient-Level Pooled Analysis of 6,081 Patients.
Piccolo R; Pilgrim T; Heg D; Franzone A; Rat-Wirtzler J; Räber L; Silber S; Serruys PW; Jüni P; Windecker S
JACC Cardiovasc Interv; 2015 Nov; 8(13):1657-66. PubMed ID: 26585615
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous Coronary Intervention of Left Main Disease: Pre- and Post-EXCEL (Evaluation of XIENCE Everolimus Eluting Stent Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) and NOBLE (Nordic-Baltic-British Left Main Revascularization Study) Era.
Park DW; Park SJ
Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28607000
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data.
Hakeem A; Garg N; Bhatti S; Rajpurohit N; Ahmed Z; Uretsky BF
J Am Heart Assoc; 2013 Aug; 2(4):e000354. PubMed ID: 23926119
[TBL] [Abstract][Full Text] [Related]
33. Coronary artery bypass graft surgery versus percutaneous coronary intervention with first-generation drug-eluting stents: a meta-analysis of randomized controlled trials.
Al Ali J; Franck C; Filion KB; Eisenberg MJ
JACC Cardiovasc Interv; 2014 May; 7(5):497-506. PubMed ID: 24746647
[TBL] [Abstract][Full Text] [Related]
34. Coronary artery bypass graft surgery versus percutaneous coronary intervention with drug-eluting stents for left main coronary artery disease: A meta-analysis of randomized trials.
Putzu A; Gallo M; Martino EA; Ferrari E; Pedrazzini G; Moccetti T; Cassina T
Int J Cardiol; 2017 Aug; 241():142-148. PubMed ID: 28438354
[TBL] [Abstract][Full Text] [Related]
35. Coronary Artery Bypass Grafting or Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Diabetic Patients With Multivessel Disease.
Di Gioia G; Soto Flores N; Franco D; Colaiori I; Sonck J; Gigante C; Kodeboina M; Bartunek J; Vanderheyden M; Van Praet F; Casselman F; Degriek I; Stockman B; Barbato E; Collet C; De Bruyne B
Circ Cardiovasc Interv; 2020 Oct; 13(10):e009157. PubMed ID: 33040579
[TBL] [Abstract][Full Text] [Related]
36. The comparative efficacy of percutaneous and surgical coronary revascularization in 2009: a review.
May SA; Wilson JM
Tex Heart Inst J; 2009; 36(5):375-86. PubMed ID: 19876412
[TBL] [Abstract][Full Text] [Related]
37. Drug-Eluting Stents Versus Bare-Metal Stents in Saphenous Vein Graft Intervention.
Patel NJ; Bavishi C; Atti V; Tripathi A; Nalluri N; Cohen MG; Kini AS; Sharma SK; Dangas G; Bhatt DL
Circ Cardiovasc Interv; 2018 Nov; 11(11):e007045. PubMed ID: 30571204
[TBL] [Abstract][Full Text] [Related]
38. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
; Windecker S; Kolh P; Alfonso F; Collet JP; Cremer J; Falk V; Filippatos G; Hamm C; Head SJ; Jüni P; Kappetein AP; Kastrati A; Knuuti J; Landmesser U; Laufer G; Neumann FJ; Richter DJ; Schauerte P; Sousa Uva M; Stefanini GG; Taggart DP; Torracca L; Valgimigli M; Wijns W; Witkowski A
Eur Heart J; 2014 Oct; 35(37):2541-619. PubMed ID: 25173339
[No Abstract] [Full Text] [Related]
39. Long-Term (10-Year) Outcomes of Stenting or Bypass Surgery for Left Main Coronary Artery Disease in Patients With and Without Diabetes Mellitus.
Lee K; Ahn JM; Yoon YH; Kang DY; Park SY; Ko E; Park H; Cho SC; Park S; Kim TO; Lee PH; Lee SW; Park SW; Park DW; Park SJ
J Am Heart Assoc; 2020 Apr; 9(8):e015372. PubMed ID: 32310027
[TBL] [Abstract][Full Text] [Related]
40. Two-year outcomes after treatment of severely calcified coronary lesions with the orbital atherectomy system and the impact of stent types: Insight from the ORBIT II trial.
Généreux P; Bettinger N; Redfors B; Lee AC; Kim CY; Lee MS; Shlofmitz RA; Moses JW; Stone GW; Chambers JW
Catheter Cardiovasc Interv; 2016 Sep; 88(3):369-77. PubMed ID: 27084293
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
